Skip to main content
. 2018 Sep 5;132(16):1664–1674. doi: 10.1182/blood-2018-04-846626

Table 3.

AEs during study regardless of cause

AE All (N = 46) Grade 3/4 (n = 31 [67%]) Grade 1/2 (n = 36 [78%])
No. % No. % No. %
Nonhematologic
 Infection 15 33 5 11 10 22
 Constipation 10 22 10 22
 Nausea 7 15 1 2 6 13
 Elevated ALT, AST 5 11 1 2 4 9
 Diarrhea 4 9 1 2 3 7
 Fatigue 3 7 1 2 2 4
 Fever 3 7 2 4 1 2
 Insomnia 2 4 2 4
 Pruritus 2 4 1 2 1 2
 Dizziness 2 4 2 4
 Elevated creatinine 2 4 2 4
 Chest pain, hypertension, CHF 2 4 1 2 1 2
 Hemorrhage 2 4 1 2 1 2
 Neuropathy 1 2 1 2
 Hyperuricemia 1 2 1 2
 Anorexia 1 2 1 2
 Weight loss 1 2 1 2
Hematologic
 Neutropenia 16 35 11 14 5 11
 Anemia 33 72 21 46 12 26
 Thrombocytopenia 29 63 14 30 15 33
 New onset anemia 26 57 16 35 10 22
 New onset neutropenia 13 28 11 24 2 4
 New onset thrombocytopenia 17 37 12 26 5 11

Only 1 AE of similar type is counted in the same patient regardless of total episodes; only the highest grade of AE is reported in a patient who experienced repeated similar AEs of different grades; and percentage is calculated from all patients enrolled on the study.

ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHF, congestive heart failure.